Welcome to CART!
The Brigham and Women's Hospital Center for Alzheimer Research and Treatment (CART) resumes on site appointments this month on a limited basis. Staff are eager to welcome back participants and study partners of ongoing clinical trials and are taking precautions to keep everyone safe, including: wearing masks; limiting the number, and duration of, exposures; screening staff and participants and study partners for COVID-19 symptoms 24-72 hours prior to visits, and sanitizing exam and testing rooms before and after every visit. For a list of other precautions being taken at CART, see the attached document.
Please see the Massachusetts Alzheimer Disease Research Center 2020 Newsletter for more information about Alzheimer research and our research teams.
The Center for Alzheimer Research and Treatment, under the direction of Dr. Reisa Sperling, is affiliated with the Department of Neurology at Brigham and Women’s Hospital and Harvard Medical School. Our mission is two-fold: to assess promising new treatments for Alzheimer's disease through clinical trials and to improve early diagnosis of Alzheimer’s disease by employing more sensitive clinical evaluations, biological markers, and neuroimaging techniques.
Support Our Work at CART